{"parse":{"title":"Medicines Patent Pool","pageid":39791125,"revid":853864776,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"plainlinks metadata ambox ambox-content ambox-multiple_issues compact-ambox\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/60px-Ambox_important.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/80px-Ambox_important.svg.png 2x\" data-file-width=\"40\" data-file-height=\"40\" /></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\"><div class=\"mw-collapsible\" style=\"width:95%; margin: 0.2em 0;\"><b>This article has multiple issues.</b> Please help <b><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Medicines_Patent_Pool&amp;action=edit\">improve it</a></b> or discuss these issues on the <b><a href=\"/wiki/Talk:Medicines_Patent_Pool\" title=\"Talk:Medicines Patent Pool\">talk page</a></b>. <small><i>(<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove these template messages</a>)</i></small>\n<div class=\"mw-collapsible-content\" style=\"margin-top: 0.3em;\">\n      <table class=\"plainlinks metadata ambox ambox-content ambox-COI\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"Unbalanced scales.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Unbalanced_scales.svg/45px-Unbalanced_scales.svg.png\" width=\"45\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Unbalanced_scales.svg/68px-Unbalanced_scales.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/fe/Unbalanced_scales.svg/90px-Unbalanced_scales.svg.png 2x\" data-file-width=\"400\" data-file-height=\"354\" /></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\"><b> A major contributor to this article appears to have a <a href=\"/wiki/Wikipedia:Conflict_of_interest\" title=\"Wikipedia:Conflict of interest\">close connection</a> with its subject.</b><span class=\"hide-when-compact\"> It may require <a href=\"/wiki/Wikipedia:Cleanup\" title=\"Wikipedia:Cleanup\">cleanup</a> to comply with Wikipedia's content policies, particularly <a href=\"/wiki/Wikipedia:Neutral_point_of_view\" title=\"Wikipedia:Neutral point of view\">neutral point of view</a>. Please discuss further on the <a href=\"/wiki/Talk:Medicines_Patent_Pool\" title=\"Talk:Medicines Patent Pool\">talk page</a>.</span>  <small><i>(October 2017)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<table class=\"plainlinks metadata ambox ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"Question book-new.svg\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>may rely excessively on sources <a href=\"/wiki/Wikipedia:BLOGS\" class=\"mw-redirect\" title=\"Wikipedia:BLOGS\">too closely associated with the subject</a></b>, potentially preventing the article from being <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verifiable</a> and <a href=\"/wiki/Wikipedia:Neutral_point_of_view\" title=\"Wikipedia:Neutral point of view\">neutral</a>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Medicines_Patent_Pool&amp;action=edit\">improve it</a> by replacing them with more appropriate <a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\">citations</a> to <a href=\"/wiki/Wikipedia:Identifying_and_using_independent_sources\" title=\"Wikipedia:Identifying and using independent sources\">reliable, independent, third-party sources</a>.</span>  <small><i>(March 2017)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n    </div>\n</div><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Medicines_Patent_Pool&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(March 2017)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p>The <b>Medicines Patent Pool</b> (MPP) is a United Nations-backed international organisation founded in July 2010<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>, based in <a href=\"/wiki/Geneva\" title=\"Geneva\">Geneva</a>, <a href=\"/wiki/Switzerland\" title=\"Switzerland\">Switzerland</a>. Its public health driven business model aims to lower the prices of HIV, tuberculosis and hepatitis C medicines and facilitate the development of better-adapted HIV treatments through voluntary licensing and patent pooling. Its goal is to improve access to affordable and appropriate HIV, hepatitis C and tuberculosis medicines in low- and middle-income countries.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Creation\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Creation</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Financing\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Financing</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Structure\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Structure</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Activities\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Activities</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Creation\">Creation</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medicines_Patent_Pool&amp;action=edit&amp;section=1\" title=\"Edit section: Creation\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The Medicines Patent Pool Foundation was established as an independent legal entity in July 2010 with the support of Unitaid and has been fully operational since November 2010.\n</p><p>It is based on the idea that patents are intended to reward innovation, and that unless licensed, a patent can also prevent the production or sale of affordable, quality-assured generic medicines and the development of novel formulations. The Medicines Patent Pool negotiates with patent holders for licences on HIV, hepatitis C and tuberculosis medicines. These licences permit lower-cost manufacturers to distribute patented medicines in developing countries. Licences also provide the freedom to develop new treatments better suited for resource-limited settings, such as paediatric formulations and fixed-dose combinations. Competition among many manufacturers should bring prices down supporting treatment scale-up.\n</p>\n<h2><span class=\"mw-headline\" id=\"Financing\">Financing</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medicines_Patent_Pool&amp;action=edit&amp;section=2\" title=\"Edit section: Financing\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The Medicines Patent Pool was founded and is funded by <a href=\"/wiki/Unitaid\" title=\"Unitaid\">Unitaid</a>, a global health initiative that is working with partners to end <a href=\"/wiki/HIV/AIDS\" title=\"HIV/AIDS\">HIV/AIDS</a>, <a href=\"/wiki/Malaria\" title=\"Malaria\">malaria</a>, <a href=\"/wiki/Tuberculosis\" title=\"Tuberculosis\">tuberculosis</a> and hepatitis C and works to allow more affordable generic medicines to enter the marketplace in low- and middle-income countries. In its first grant phase 2010-2015, the MPP worked exclusively in the HIV field and in December 2014, Unitaid approved another funding package for MPP to continue its HIV work through 2020. In November 2015, the MPP mandate was expanded to hepatitis C and tuberculosis treatment. The Medicines Patent Pool was the first and is now the only independent <a href=\"/wiki/Patent_pool\" title=\"Patent pool\">patent pool</a> that aims to tackle the issue of access to HIV/AIDS, hepatitis C and tuberculosis drugs in low- and middle-income countries.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Structure\">Structure</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medicines_Patent_Pool&amp;action=edit&amp;section=3\" title=\"Edit section: Structure\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The MPP has two governing bodies: a Governance board (i.e.<a href=\"/wiki/Executive_Board\" class=\"mw-redirect\" title=\"Executive Board\">Executive Board</a>) composed of 9 members and an Expert Advisory Group comprising 12 members , it also works with ad hoc experts.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup>\n</p><p>The current Chair of the Governance Board is World Health Organization (WHO)\u2019s former Assistant Director-General for Health Systems and Innovation Marie-Paule Kieny,<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> who succeeded Sigrun M\u00f8gedal, chair since March 2016 and Charles Clift, the MPP\u2019s founding chairman.\n</p><p>Executive Directors: Charles Gore (2018), Greg Perry (2013-2017), <a href=\"/wiki/Ellen_%27t_Hoen\" title=\"Ellen &#39;t Hoen\">Ellen 't Hoen</a> (2010-2012).\n</p>\n<h2><span class=\"mw-headline\" id=\"Activities\">Activities</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medicines_Patent_Pool&amp;action=edit&amp;section=4\" title=\"Edit section: Activities\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The Medicines Patent Pool negotiates public-health driven licences with patent holders, and sub-licenses to generic manufacturers to encourage the sale of lower-cost generic versions of medicines in over a hundred developing countries.\n</p><p>In October 2012, the MPP, Gilead Sciences and the UN National Institutes of Health/University of Illinois were honoured by the <a href=\"/wiki/Licensing_Executives_Society\" class=\"mw-redirect\" title=\"Licensing Executives Society\">Licensing Executives Society</a> (United States and Canada) (LES) for licence agreements that expand access to affordable HIV medicines in developing countries. The LES\u2019s annual \"Deals of Distinction\" Awards are presented to notable intellectual property agreements in five industry sectors and the three parties were recognised for precedence-setting licensing agreements dedicated to improving public health under the Industry-University-Government Interface category.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>\n</p><p>As of 2018, the Medicines Patent Pool holds licences for 13 HIV antiretrovirals, an HIV technology platform, 2 hepatitis C direct-acting antivirals and 1 investigational treatment for tuberculosis from patent holders <a href=\"/wiki/AbbVie\" class=\"mw-redirect\" title=\"AbbVie\">AbbVie</a>,<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup> <a href=\"/wiki/Bristol-Myers_Squibb\" title=\"Bristol-Myers Squibb\">Bristol-Myers Squibb</a><sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>, <a href=\"/wiki/Gilead_Sciences\" title=\"Gilead Sciences\">Gilead Sciences</a><sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup><sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup>, <a href=\"/wiki/Merck_Sharp_and_Dohme\" class=\"mw-redirect\" title=\"Merck Sharp and Dohme\">MSD</a><sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup>, <a href=\"/wiki/ViiV_Healthcare\" title=\"ViiV Healthcare\">ViiV Healthcare</a><sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup>, <a href=\"/wiki/Johns_Hopkins_University\" title=\"Johns Hopkins University\">Johns Hopkins University</a><sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup>, the University of Liverpool, the <a href=\"/wiki/US_National_Institutes_of_Health\" class=\"mw-redirect\" title=\"US National Institutes of Health\">US National Institutes of Health</a><sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup> and Pharco Pharmaceuticals<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup>. The MPP also worked with <a href=\"/wiki/Janssen_Pharmaceutica\" title=\"Janssen Pharmaceutica\">Janssen</a><sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup> and <a href=\"/wiki/Boehringer_Ingelheim\" title=\"Boehringer Ingelheim\">Boehringer Ingelheim</a><sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup> to extend their non-assert policies for paediatric darunavir formulations and nevirapine, ensuring that the companies will not assert their patent rights in many more developing countries. The organisation signed an agreement with <a href=\"/wiki/F._Hoffmann-La_Roche\" class=\"mw-redirect\" title=\"F. Hoffmann-La Roche\">F. Hoffmann-La Roche</a><sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup> to increase access to valganciclovir, an important treatment for an HIV opportunistic infection.\n</p><p>In 2018, the foundation announced a new five-year strategy<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup> to improve access to medicines in low- and middle-income countries, which supports international public health goals for HIV, tuberculosis and hepatitis C.\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Medicines_Patent_Pool&amp;action=edit&amp;section=5\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://www.unitaid.eu/images/EB11/05%20_eb11%20res.5%20implementation%20of%20patent%20pool.pdf\">http://www.unitaid.eu/images/EB11/05%20_eb11%20res.5%20implementation%20of%20patent%20pool.pdf</a><sup class=\"noprint Inline-Template\"><span style=\"white-space: nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Link_rot\" title=\"Wikipedia:Link rot\"><span title=\"&#160;Dead link since January 2018\">permanent dead link</span></a></i>&#93;</span></sup></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ip-watch.org/2015/11/09/medicines-patent-pool-expands-to-include-hepatitis-c-tuberculosis/\">\"Medicines Patent Pool Expands To Include Hepatitis C, Tuberculosis\"</a>. IP Watch. 9 November 2015<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 October</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Medicines+Patent+Pool+Expands+To+Include+Hepatitis+C%2C+Tuberculosis&amp;rft.date=2015-11-09&amp;rft_id=https%3A%2F%2Fwww.ip-watch.org%2F2015%2F11%2F09%2Fmedicines-patent-pool-expands-to-include-hepatitis-c-tuberculosis%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.medicinespatentpool.org/who-we-are2/governance/\">\"Governance - Medicines Patent Pool\"</a>. <i>medicinespatentpool.org/staffing-and-governance/</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=medicinespatentpool.org%2Fstaffing-and-governance%2F&amp;rft.atitle=Governance+-+Medicines+Patent+Pool&amp;rft_id=http%3A%2F%2Fwww.medicinespatentpool.org%2Fwho-we-are2%2Fgovernance%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.ip-watch.org/2017/07/03/medicines-patent-pool-nets-whos-kieny-new-chair/\">\"Medicines Patent Pool Nets WHO's Kieny As New Chair\"</a>. IP Watch. 3 July 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 October</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Medicines+Patent+Pool+Nets+WHO%E2%80%99s+Kieny+As+New+Chair&amp;rft.date=2017-07-03&amp;rft_id=https%3A%2F%2Fwww.ip-watch.org%2F2017%2F07%2F03%2Fmedicines-patent-pool-nets-whos-kieny-new-chair%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://archive.is/20130628042452/http://www.lesusacanada.org/newsroom/press-releases/2012/10/11/five-landmark-ip-deals-receive-licensing-executives-society-s-prestigious-2012-deals-of-distinction-awards\">\"Five Landmark IP Deals Receive Licensing Executives Society's Prestigious 2012 Deals of Distinction\u2122 Awards\"</a>. <i>lesusacanada.org</i>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.lesusacanada.org/newsroom/press-releases/2012/10/11/five-landmark-ip-deals-receive-licensing-executives-society-s-prestigious-2012-deals-of-distinction-awards\">the original</a> on 2013-06-28.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=lesusacanada.org&amp;rft.atitle=Five+Landmark+IP+Deals+Receive+Licensing+Executives+Society%E2%80%99s+Prestigious+2012+Deals+of+Distinction%E2%84%A2+Awards&amp;rft_id=http%3A%2F%2Fwww.lesusacanada.org%2Fnewsroom%2Fpress-releases%2F2012%2F10%2F11%2Ffive-landmark-ip-deals-receive-licensing-executives-society-s-prestigious-2012-deals-of-distinction-awards&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/2014/12/01/us-health-aids-children-medicine-idUSKCN0JF10820141201\">\"AbbVie adds children's AIDS drugs to shared patent pool\"</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=AbbVie+adds+children%27s+AIDS+drugs+to+shared+patent+pool&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2014%2F12%2F01%2Fus-health-aids-children-medicine-idUSKCN0JF10820141201&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Kalil, Tom; Steffen, Robynn. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.whitehouse.gov/blog/2013/12/12/bristol-myers-squibb-and-medicines-patent-pool-increase-access-critical-hiv-drug\">\"Bristol-Myers Squibb and Medicines Patent Pool Increase Access to Critical HIV Drug\"</a>. <i>White House - Office of Science and  Technology Policy</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 April</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=White+House+-+Office+of+Science+and++Technology+Policy&amp;rft.atitle=Bristol-Myers+Squibb+and+Medicines+Patent+Pool+Increase+Access+to+Critical+HIV+Drug&amp;rft.aulast=Kalil&amp;rft.aufirst=Tom&amp;rft.au=Steffen%2C+Robynn&amp;rft_id=https%3A%2F%2Fwww.whitehouse.gov%2Fblog%2F2013%2F12%2F12%2Fbristol-myers-squibb-and-medicines-patent-pool-increase-access-critical-hiv-drug&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">HIRSCHLER, BEN. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/2011/07/12/us-aids-patents-idUSTRE76B0YW20110712\">\"Gilead kickstarts patent pool for AIDS drugs\"</a>. <i>Reuters</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">16 April</span> 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Reuters&amp;rft.atitle=Gilead+kickstarts+patent+pool+for+AIDS+drugs&amp;rft.aulast=HIRSCHLER&amp;rft.aufirst=BEN&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2011%2F07%2F12%2Fus-aids-patents-idUSTRE76B0YW20110712&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2011/july/20110712pspatentpool/\">\"UNAIDS\"</a>. <i>unaids.org</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=unaids.org&amp;rft.atitle=UNAIDS&amp;rft_id=http%3A%2F%2Fwww.unaids.org%2Fen%2Fresources%2Fpresscentre%2Fpressreleaseandstatementarchive%2F2011%2Fjuly%2F20110712pspatentpool%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">William New. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.ip-watch.org/2015/02/24/medicines-patent-pool-nails-down-another-key-paediatric-drug/\">\"Medicines Patent Pool Nails Down Another Key Paediatric Drug\"</a>. <i>Intellectual Property Watch</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Intellectual+Property+Watch&amp;rft.atitle=Medicines+Patent+Pool+Nails+Down+Another+Key+Paediatric+Drug&amp;rft.au=William+New&amp;rft_id=http%3A%2F%2Fwww.ip-watch.org%2F2015%2F02%2F24%2Fmedicines-patent-pool-nails-down-another-key-paediatric-drug%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20130618090506/http://viivhealthcare.com/media-room/press-releases/2013-02-27.aspx?sc_lang=en\">\"Archived copy\"</a>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.viivhealthcare.com/media-room/press-releases/2013-02-27.aspx?sc_lang=en\">the original</a> on 2013-06-18<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2013-06-27</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Archived+copy&amp;rft_id=http%3A%2F%2Fwww.viivhealthcare.com%2Fmedia-room%2Fpress-releases%2F2013-02-27.aspx%3Fsc_lang%3Den&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.reuters.com/article/2014/04/01/aids-drug-viiv-idUSL5N0MT59F20140401\">\"GSK's ViiV unit adds new HIV drug to AIDS patent pool\"</a>. <i>Reuters</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Reuters&amp;rft.atitle=GSK%27s+ViiV+unit+adds+new+HIV+drug+to+AIDS+patent+pool&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2F2014%2F04%2F01%2Faids-drug-viiv-idUSL5N0MT59F20140401&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.prnewswire.com/news-releases/the-medicines-patent-pool-announces-first-licence-for-tuberculosis-treatment-611702695.html\">\"The Medicines Patent Pool Announces First Licence for Tuberculosis Treatment\"</a>. Cision. PR Newswire. 24 January 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 October</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+Medicines+Patent+Pool+Announces+First+Licence+for+Tuberculosis+Treatment&amp;rft.date=2017-01-24&amp;rft_id=http%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fthe-medicines-patent-pool-announces-first-licence-for-tuberculosis-treatment-611702695.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20131024012832/http://www.doctorswithoutborders.org/press/release.cfm?id=4768&amp;cat=press-release\">\"Press room\"</a>. <i>MSF USA</i>. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://www.doctorswithoutborders.org/press/release.cfm?id=4768&amp;cat=press-release\">the original</a> on 2013-10-24.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=MSF+USA&amp;rft.atitle=Press+room&amp;rft_id=http%3A%2F%2Fwww.doctorswithoutborders.org%2Fpress%2Frelease.cfm%3Fid%3D4768%26cat%3Dpress-release&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation news\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.prnewswire.com/news-releases/the-medicines-patent-pool-and-pharco-pharmaceuticals-sign-licence-for-promising-hepatitis-c-drug-candidate-ravidasvir-620046483.html\">\"The Medicines Patent Pool and Pharco Pharmaceuticals Sign Licence for Promising Hepatitis C Drug Candidate Ravidasvir\"</a>. Cision. PR newswire. 21 April 2017<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 October</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+Medicines+Patent+Pool+and+Pharco+Pharmaceuticals+Sign+Licence+for+Promising+Hepatitis+C+Drug+Candidate+Ravidasvir&amp;rft.date=2017-04-21&amp;rft_id=http%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fthe-medicines-patent-pool-and-pharco-pharmaceuticals-sign-licence-for-promising-hepatitis-c-drug-candidate-ravidasvir-620046483.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://medicinespatentpool.org/mpp-media-post/the-medicines-patent-pool-on-janssens-extension-of-its-access-policy-for-paediatric-medicine-darunavir-statement/\">\"The Medicines Patent Pool on Janssen's Extension of its Access Policy for Paediatric Medicine Darunavir\"</a>. <i>Medicines Patent Pool</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 October</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Medicines+Patent+Pool&amp;rft.atitle=The+Medicines+Patent+Pool+on+Janssen%E2%80%99s+Extension+of+its+Access+Policy+for+Paediatric+Medicine+Darunavir&amp;rft_id=https%3A%2F%2Fmedicinespatentpool.org%2Fmpp-media-post%2Fthe-medicines-patent-pool-on-janssens-extension-of-its-access-policy-for-paediatric-medicine-darunavir-statement%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.boehringer-ingelheim.com/press-release/boehringer-ingelheim-increases-access-medication-treatment-hivaids\">\"Boehringer Ingelheim increases access to the medication for the treatment of HIV/Aids\"</a>. <i>Boehringer Ingelheim</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">9 October</span> 2017</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Boehringer+Ingelheim&amp;rft.atitle=Boehringer+Ingelheim+increases+access+to+the+medication+for+the+treatment+of+HIV%2FAids&amp;rft_id=https%3A%2F%2Fwww.boehringer-ingelheim.com%2Fpress-release%2Fboehringer-ingelheim-increases-access-medication-treatment-hivaids&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.roche.com/dam/jcr:3a1638ce-fe8c-46f2-b868-40f67bba3b28/en/med-cor-2013-08-05-e.pdf\">\"Roche-MPP agreement\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i><a rel=\"nofollow\" class=\"external free\" href=\"https://www.roche.com/dam/jcr:3a1638ce-fe8c-46f2-b868-40f67bba3b28/en/med-cor-2013-08-05-e.pdf\">https://www.roche.com/dam/jcr:3a1638ce-fe8c-46f2-b868-40f67bba3b28/en/med-cor-2013-08-05-e.pdf</a></i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=https%3A%2F%2Fwww.roche.com%2Fdam%2Fjcr%3A3a1638ce-fe8c-46f2-b868-40f67bba3b28%2Fen%2Fmed-cor-2013-08-05-e.pdf&amp;rft.atitle=Roche-MPP+agreement&amp;rft_id=https%3A%2F%2Fwww.roche.com%2Fdam%2Fjcr%3A3a1638ce-fe8c-46f2-b868-40f67bba3b28%2Fen%2Fmed-cor-2013-08-05-e.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">External link in <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;website=</code> (<a href=\"/wiki/Help:CS1_errors#param_has_ext_link\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.prnewswire.com/news-releases/the-medicines-patent-pool-presents-new-five-year-strategy-for-improving-access-to-priority-treatments-in-developing-countries-683608381.html\">\"The Medicines Patent Pool presents new five-year strategy\"</a>. <i><a rel=\"nofollow\" class=\"external free\" href=\"https://www.prnewswire.com\">https://www.prnewswire.com</a></i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2018-08-05</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=https%3A%2F%2Fwww.prnewswire.com&amp;rft.atitle=The+Medicines+Patent+Pool+presents+new+five-year+strategy&amp;rft_id=https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fthe-medicines-patent-pool-presents-new-five-year-strategy-for-improving-access-to-priority-treatments-in-developing-countries-683608381.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AMedicines+Patent+Pool\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">External link in <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;website=</code> (<a href=\"/wiki/Help:CS1_errors#param_has_ext_link\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n</ol></div></div>\n\n<!-- \nNewPP limit report\nParsed by mw1318\nCached time: 20180909021231\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.240 seconds\nReal time usage: 0.283 seconds\nPreprocessor visited node count: 1113/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 58423/2097152 bytes\nTemplate argument size: 7250/2097152 bytes\nHighest expansion depth: 16/40\nExpensive parser function count: 4/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 21229/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.119/10.000 seconds\nLua memory usage: 4.34 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  248.394      1 -total\n 58.48%  145.253      1 Template:Reflist\n 37.89%   94.107      4 Template:Ambox\n 32.15%   79.866      1 Template:Multiple_issues\n 21.73%   53.987     14 Template:Cite_web\n 20.98%   52.124      4 Template:Cite_news\n  8.76%   21.761      1 Template:COI\n  7.65%   19.003      1 Template:Third-party\n  6.54%   16.244      1 Template:Dead_link\n  5.62%   13.949      1 Template:DMCA\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:39791125-0!canonical and timestamp 20180909021231 and revision id 853864776\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"All_articles_with_dead_external_links"},{"sortkey":"","hidden":"","*":"Articles_with_dead_external_links_from_January_2018"},{"sortkey":"","hidden":"","*":"Articles_with_permanently_dead_external_links"},{"sortkey":"","hidden":"","*":"CS1_errors:_external_links"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_with_possible_conflicts_of_interest_from_October_2017"},{"sortkey":"","hidden":"","*":"Articles_lacking_reliable_references_from_March_2017"},{"sortkey":"","hidden":"","*":"All_articles_lacking_reliable_references"},{"sortkey":"","hidden":"","*":"Articles_with_multiple_maintenance_issues"},{"sortkey":"","hidden":"","*":"Articles_needing_additional_references_from_March_2017"},{"sortkey":"","hidden":"","*":"All_articles_needing_additional_references"},{"sortkey":"","*":"HIV/AIDS_organizations"},{"sortkey":"","*":"Malaria_organizations"},{"sortkey":"","*":"Tuberculosis_organizations"},{"sortkey":"","*":"International_medical_and_health_organizations"},{"sortkey":"","*":"International_organisations_based_in_Switzerland"}],"links":[{"ns":14,"exists":"","*":"Category:Wikipedia articles with possible conflicts of interest from October 2017"},{"ns":14,"exists":"","*":"Category:Articles lacking reliable references from March 2017"},{"ns":14,"exists":"","*":"Category:Articles needing additional references from March 2017"},{"ns":14,"exists":"","*":"Category:Articles with dead external links from January 2018"},{"ns":0,"exists":"","*":"AbbVie"},{"ns":0,"exists":"","*":"Boehringer Ingelheim"},{"ns":0,"exists":"","*":"Bristol-Myers Squibb"},{"ns":0,"exists":"","*":"Ellen 't Hoen"},{"ns":0,"exists":"","*":"Executive Board"},{"ns":0,"exists":"","*":"F. Hoffmann-La Roche"},{"ns":0,"exists":"","*":"Geneva"},{"ns":0,"exists":"","*":"Gilead Sciences"},{"ns":0,"exists":"","*":"HIV/AIDS"},{"ns":0,"exists":"","*":"Janssen Pharmaceutica"},{"ns":0,"exists":"","*":"Johns Hopkins University"},{"ns":0,"exists":"","*":"Licensing Executives Society"},{"ns":0,"exists":"","*":"Malaria"},{"ns":0,"exists":"","*":"Merck Sharp and Dohme"},{"ns":0,"exists":"","*":"Patent pool"},{"ns":0,"exists":"","*":"Switzerland"},{"ns":0,"exists":"","*":"Tuberculosis"},{"ns":0,"exists":"","*":"US National Institutes of Health"},{"ns":0,"exists":"","*":"Unitaid"},{"ns":0,"exists":"","*":"ViiV Healthcare"},{"ns":1,"exists":"","*":"Talk:Medicines Patent Pool"},{"ns":4,"exists":"","*":"Wikipedia:BLOGS"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:Cleanup"},{"ns":4,"exists":"","*":"Wikipedia:Conflict of interest"},{"ns":4,"exists":"","*":"Wikipedia:Identifying and using independent sources"},{"ns":4,"exists":"","*":"Wikipedia:Link rot"},{"ns":4,"exists":"","*":"Wikipedia:Neutral point of view"},{"ns":4,"exists":"","*":"Wikipedia:Verifiability"},{"ns":12,"exists":"","*":"Help:CS1 errors"},{"ns":12,"exists":"","*":"Help:Introduction to referencing with Wiki Markup/1"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"}],"templates":[{"ns":10,"exists":"","*":"Template:Multiple issues"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:COI"},{"ns":10,"exists":"","*":"Template:Third-party"},{"ns":10,"exists":"","*":"Template:DMCA"},{"ns":10,"exists":"","*":"Template:Dated maintenance category"},{"ns":10,"exists":"","*":"Template:FULLROOTPAGENAME"},{"ns":10,"exists":"","*":"Template:Ns has subpages"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:More citations needed"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Dead link"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Cite news"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Ns has subpages"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"}],"images":["Ambox_important.svg","Unbalanced_scales.svg","Question_book-new.svg"],"externallinks":["https://www.ip-watch.org/2015/11/09/medicines-patent-pool-expands-to-include-hepatitis-c-tuberculosis/","http://www.medicinespatentpool.org/who-we-are2/governance/","https://www.ip-watch.org/2017/07/03/medicines-patent-pool-nets-whos-kieny-new-chair/","https://archive.is/20130628042452/http://www.lesusacanada.org/newsroom/press-releases/2012/10/11/five-landmark-ip-deals-receive-licensing-executives-society-s-prestigious-2012-deals-of-distinction-awards","http://www.lesusacanada.org/newsroom/press-releases/2012/10/11/five-landmark-ip-deals-receive-licensing-executives-society-s-prestigious-2012-deals-of-distinction-awards","https://www.reuters.com/article/2014/12/01/us-health-aids-children-medicine-idUSKCN0JF10820141201","https://www.whitehouse.gov/blog/2013/12/12/bristol-myers-squibb-and-medicines-patent-pool-increase-access-critical-hiv-drug","https://www.reuters.com/article/2011/07/12/us-aids-patents-idUSTRE76B0YW20110712","http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2011/july/20110712pspatentpool/","http://www.ip-watch.org/2015/02/24/medicines-patent-pool-nails-down-another-key-paediatric-drug/","https://web.archive.org/web/20130618090506/http://viivhealthcare.com/media-room/press-releases/2013-02-27.aspx?sc_lang=en","http://www.viivhealthcare.com/media-room/press-releases/2013-02-27.aspx?sc_lang=en","https://www.reuters.com/article/2014/04/01/aids-drug-viiv-idUSL5N0MT59F20140401","http://www.prnewswire.com/news-releases/the-medicines-patent-pool-announces-first-licence-for-tuberculosis-treatment-611702695.html","https://web.archive.org/web/20131024012832/http://www.doctorswithoutborders.org/press/release.cfm?id=4768&cat=press-release","http://www.doctorswithoutborders.org/press/release.cfm?id=4768&cat=press-release","http://www.prnewswire.com/news-releases/the-medicines-patent-pool-and-pharco-pharmaceuticals-sign-licence-for-promising-hepatitis-c-drug-candidate-ravidasvir-620046483.html","https://medicinespatentpool.org/mpp-media-post/the-medicines-patent-pool-on-janssens-extension-of-its-access-policy-for-paediatric-medicine-darunavir-statement/","https://www.boehringer-ingelheim.com/press-release/boehringer-ingelheim-increases-access-medication-treatment-hivaids","https://www.roche.com/dam/jcr:3a1638ce-fe8c-46f2-b868-40f67bba3b28/en/med-cor-2013-08-05-e.pdf","https://www.prnewswire.com/news-releases/the-medicines-patent-pool-presents-new-five-year-strategy-for-improving-access-to-priority-treatments-in-developing-countries-683608381.html","http://www.unitaid.eu/images/EB11/05%20_eb11%20res.5%20implementation%20of%20patent%20pool.pdf","https://www.prnewswire.com"],"sections":[{"toclevel":1,"level":"2","line":"Creation","number":"1","index":"1","fromtitle":"Medicines_Patent_Pool","byteoffset":821,"anchor":"Creation"},{"toclevel":1,"level":"2","line":"Financing","number":"2","index":"2","fromtitle":"Medicines_Patent_Pool","byteoffset":1734,"anchor":"Financing"},{"toclevel":1,"level":"2","line":"Structure","number":"3","index":"3","fromtitle":"Medicines_Patent_Pool","byteoffset":2816,"anchor":"Structure"},{"toclevel":1,"level":"2","line":"Activities","number":"4","index":"4","fromtitle":"Medicines_Patent_Pool","byteoffset":3797,"anchor":"Activities"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"5","fromtitle":"Medicines_Patent_Pool","byteoffset":10454,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Medicines Patent Pool","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q17006726"}]}}